SCHEMBL5834865

SCHEMBL5834865

CCN(CC)c1ccc(NC(=O)C2(C(=O)OC)CCc3cccc(OC)c3C2)c(C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.56
GFER P55789 6/20 0.56
MAPK1 P28482 5/20 0.56
ALDH1A1 P00352 4/20 0.56
NPSR1 Q6W5P4 2/20 0.56
GHSR Q92847 3/20 0.49
KCNH2 Q12809 1/20 0.49
LMNA P02545 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HSD17B10 Q99714 2/20 0.48
ALOX15 P16050 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HTT P42858 3/20 0.47
POLB P06746 2/20 0.44
CYP2C19 P33261 2/20 0.43
CYP1A2 P05177 1/20 0.43
TP53 P04637 1/20 0.41
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835215 0.79 GHSR (0.80) MAPTGFERMAPK1ALDH1A1NPSR1
SCHEMBL5835247 0.74 GHSR (0.64) MAPTGFERMAPK1ALDH1A1NPSR1
SCHEMBL5835478 0.73 ADRA2A (0.46) MAPTGHSRKCNH2ALOX15CYP1A2
SCHEMBL5836093 0.71 GHSR (0.58) MAPTGFERMAPK1ALDH1A1NPSR1
SCHEMBL5835137 0.69 MTNR1A (0.44) MAPTGHSRKCNH2ALOX15CYP1A2
SCHEMBL5835587 0.69 GHSR (0.63) MAPTGFERMAPK1ALDH1A1NPSR1
SCHEMBL5834813 0.69 GHSR (0.63) MAPTGFERMAPK1ALDH1A1NPSR1
SCHEMBL5835936 0.69 GHSR (0.50) MAPTGFERMAPK1ALDH1A1NPSR1
SCHEMBL5835556 0.68 GHSR (0.77) MAPTGFERMAPK1ALDH1A1NPSR1
SCHEMBL5834819 0.68 GHSR (0.43) MAPTGFERMAPK1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR MAPT 3095/4885GFER 3648/4885MAPK1 413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.